Table 2.
Adjusted prevalence of statin eligibility among those not on statins (N = 6043), without (Model I) and with (Model II) adjustment for access/utilization.
| Model I | Model II | |||||||
|---|---|---|---|---|---|---|---|---|
| Social Risk Factor | AME | 95% CI | P | AME | 95% CI | P | ||
| Age group | ||||||||
| 21-34 (reference) | ||||||||
| 35 | 7.66 | 3.11 | 12.21 | <0.01 | 6.74 | 2.61 | 10.88 | <0.01 |
| 45 | 18.96 | 11.72 | 26.20 | <0.01 | 16.96 | 10.16 | 23.76 | <0.01 |
| 55 | 29.84 | 21.76 | 37.93 | <0.01 | 26.90 | 19.08 | 34.71 | <0.01 |
| ≥ 65 | 42.48 | 34.32 | 50.65 | <0.01 | 38.28 | 30.35 | 46.20 | <0.01 |
| Female | -11.54 | -12.57 | -10.50 | <0.01 | -11.69 | -12.75 | -10.63 | <0.01 |
| Race/Ethnicity | ||||||||
| White (reference) | ||||||||
| Black | -0.66 | -1.81 | 0.49 | 0.26 | -0.57 | -1.54 | 0.40 | 0.25 |
| Hispanic | -2.62 | -3.74 | -1.49 | 0.00 | -1.65 | -2.99 | -0.30 | 0.02 |
| Other | 1.91 | -1.48 | 5.30 | 0.27 | 2.28 | -1.14 | 5.70 | 0.19 |
| Federal Poverty Level (%) | ||||||||
| <100 (reference) | ||||||||
| 100-149 | -2.52 | -4.86 | -0.19 | 0.03 | -2.22 | -4.23 | -0.21 | 0.03 |
| 149-199 | -2.53 | -5.76 | 0.70 | 0.12 | -2.17 | -5.01 | 0.66 | 0.13 |
| 200-299 | -3.31 | -5.54 | -1.08 | <0.01 | -2.91 | -4.90 | -0.93 | <0.01 |
| 300-499 | -5.66 | -8.82 | -2.49 | <0.01 | -5.01 | -7.80 | -2.21 | <0.01 |
| ≥ 500 | -3.76 | -5.46 | -2.06 | <0.01 | -3.34 | -4.79 | -1.89 | <0.01 |
| Education (years) | ||||||||
| <12 (reference) | ||||||||
| 12 | 0.10 | -1.73 | 1.93 | 0.92 | -0.05 | -1.66 | 1.56 | 0.95 |
| >12 | -2.34 | -3.90 | -0.79 | <0.01 | -2.09 | -3.48 | -0.70 | <0.01 |
Notes: AME = adjusted average marginal effect, adjusted % difference from reference group; CI = confidence interval. All analyses adjusted for survey year. Model II also adjusted for insurance, language, usual source of care, and visit number. Source: NHANES 1999-2006